SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-19-309348
Filing Date
2019-12-09
Accepted
2019-12-09 17:03:06
Documents
9

Document Format Files

Seq Description Document Type Size
1 425 d828148d425.htm 425 17140
2 GRAPHIC g828148txs1g1.jpg GRAPHIC 77819
3 GRAPHIC g828148txs2g1.jpg GRAPHIC 170307
4 GRAPHIC g828148txs3g1.jpg GRAPHIC 345214
5 GRAPHIC g828148txs4g1.jpg GRAPHIC 221804
6 GRAPHIC g828148txs5g1.jpg GRAPHIC 433689
7 GRAPHIC g828148txs6g1.jpg GRAPHIC 346295
8 GRAPHIC g828148txs7g1.jpg GRAPHIC 359251
9 GRAPHIC g828148txs8g1.jpg GRAPHIC 771172
  Complete submission text file 0001193125-19-309348.txt   3773538
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filed by) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36621 | Film No.: 191275872
SIC: 2833 Medicinal Chemicals & Botanical Products